A phase 3, randomized study of adjuvant rilvegostomig plus chemotherapy in resected biliary tract cancer: ARTEMIDE-Biliary01 Meeting Abstract
| Authors: | Fan, J.; Bekaii-Saab, T. S.; Aldrighetti, L. A.; Bridgewater, J. A.; Ferrone, C. R.; Harding, J. J.; Ikeda, M.; Knox, J. J.; Wang, J. L.; Kayhanian, H.; Chen, X.; Bai, S. Y.; Drachsler, M. W.; Oh, D. Y. |
| Abstract Title: | A phase 3, randomized study of adjuvant rilvegostomig plus chemotherapy in resected biliary tract cancer: ARTEMIDE-Biliary01 |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557406194 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.TPS4199 |
| Notes: | Meeting Abstract: TPS4199 -- Source: Wos |
